Basic Search  |  Summaries  |  Advanced SearchPenalty: £1,220,383
Year: 2021
Date: 25 February, 2021
Offence Group: competition-related offences
Offence Type: price-fixing or anti-competitive practices
Violation Description: Lexon was ordered to pay £1,220,383 by the Competition Appeal Tribunal in judgment of a decision by the CMA that the company had illegally shared commercially sensitive information with other suppliers of the drug nortriptyline to keep prices up. The other companies involved, King Pharmaceuticals and Alissa Healthcare Research, had already settled the decision and fine.
Action Type: agency action
Case Number: 50507
Agency: Competition and Markets Authority
HQ Country of Parent: United Kingdom
Ownership Structure of Parent: privately held
Major Industry of Parent: healthcare services
Specific Industry of Parent: insourcing
Source of Data: (click here)